Synthetic Polysaccharide Type 3-Related Di-, Tri-, and Tetrasaccharide–CRM197 Conjugates Induce Protection against Streptococcus pneumoniae Type 3 in Mice

AUTOR(ES)

Benaissa-Trouw, Barry

FONTE

American Society for Microbiology

RESUMO

Di-, tri-, and tetrasaccharides, synthesized according to the chemical structure of pneumococcal polysaccharide type 3 (PS3), were coupled to the cross-reactive material (CRM197) of modified diphtheria toxin in different molar carbohydrate/protein ratios using the squarate coupling method. To study protective immunity, female BALB/c mice were subcutaneously immunized twice (with a 3-week interval) using the amount of conjugates corresponding to 2.5 μg of oligosaccharide per mouse. The conjugates evoked PS3 binding immunoglobulin G antibodies that lasted for at least 7 weeks after the booster. Immunogenicity was not influenced by the carbohydrate/protein ratio. All mice with PS3-specific antibodies survived the intraperitoneal challenge with Streptococcus pneumoniae type 3. Therefore, synthetic oligosaccharide-protein conjugates might have potential as vaccines.

Documentos Relacionados

• Synthetic 6B Di-, Tri-, and Tetrasaccharide-Protein Conjugates Contain Pneumococcal Type 6A and 6B Common and 6B- Specific Epitopes That Elicit Protective Antibodies in Mice
• Relative mutation rates at di-, tri-, and tetranucleotide microsatellite loci
• Nucleosome mono, di, tri-, and tetramers from chicken embryo chromatin.
• Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3.
• Fused lacZ genes code for di-, tri- and tetra-beta-galactosidase in Escherichia coli.